CHU Toulouse-Hopital Larrey

Toulouse 31059

1 studies enrolling now · 5 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, HER2 Exon 20 Mutation, Indolent Systemic Mastocytosis, Non-small Cell Lung Cancer, Non-small Cell Lung Cancer(NSCLC), Non-squamous NSCLC, Smoldering Systemic Mastocytosis

Studies at this site

• (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis — Recruiting now
• Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01) — Running, not enrolling
• A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer — Running, not enrolling
• Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy — Completed
• A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib — Completed